Study of Sargramostim in Patients With COVID-19 (iLeukPulm)
Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)
Using GM-CSF as a Host Directed Therapeutic Against COVID-19
GM-CSF With Post-Transplant Cyclophosphamide
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Pembrolizumab and GM-CSF in Biliary Cancer
Biomarker Assessments of Leukine During Treatment of Parkinson’s Disease
Note: Not all clinical trials including sargramostim are listed.